secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Teknova, Inc. (TKNO)
CIK:        0001850902
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001193125-26-076592
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Alpha Teknova reports Q4 and FY2025 revenue growth, provides 2026 guidance of $42-44M
--------------------------------------------------------------------------------

- Full year 2025 total revenue $40.5M, up 7% from $37.7M in 2024.
- Q4 2025 revenue $10.0M, up 8% from $9.3M in Q4 2024.
- Clinical Solutions revenue up 47% in Q4 to $2.7M; 25% annual growth in Clinical Solutions customers.
- Net loss improved to $17.3M in 2025 from $26.7M in 2024; Adjusted EBITDA improved to -$6.7M from -$14.5M.
- Company expects 2026 revenue of $42-44M and free cash outflow less than $10M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850902/000119312526076592/0001193125-26-076592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850902/000119312526076592/tkno-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-076592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer